Marianna Mancini - 28 Mar 2023 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Chief Operating Officer
Signature
/s/ Michael Morneau as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
28 Mar 2023
Net transactions value
-$3,074,174
Form type
4
Filing time
30 Mar 2023, 21:04:35 UTC
Previous filing
17 Jan 2023
Next filing
03 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $32,250 +15,000 +4.7% $2.15* 332,273 28 Mar 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $9,161 +4,873 +1.5% $1.88* 337,146 28 Mar 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $18,900 +15,000 +4.4% $1.26* 352,146 28 Mar 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $65,256 +53,054 +15% $1.23* 405,200 28 Mar 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $16,200 +15,000 +3.7% $1.08* 420,200 28 Mar 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $10,400 +10,000 +2.4% $1.04* 430,200 28 Mar 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $113,925 +24,500 +5.7% $4.65 454,700 28 Mar 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $131,100 +30,000 +6.6% $4.37 484,700 28 Mar 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale $2,948,445 -196,563 -41% $15.00 288,137 28 Mar 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $136,950 +15,000 +5.2% $9.13 303,137 29 Mar 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale $659,872 -41,242 -14% $16.00 261,895 29 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (right to buy) Options Exercise $0 -15,000 -100% $0.000000* 0 28 Mar 2023 Common Stock 15,000 $2.15 Direct F1, F2
transaction VKTX Stock Option (right to buy) Options Exercise $0 -4,873 -100% $0.000000* 0 28 Mar 2023 Common Stock 4,873 $1.88 Direct F1, F3
transaction VKTX Stock Option (right to buy) Options Exercise $0 -15,000 -100% $0.000000* 0 28 Mar 2023 Common Stock 15,000 $1.26 Direct F1, F2
transaction VKTX Stock Option (right to buy) Options Exercise $0 -53,054 -100% $0.000000* 0 28 Mar 2023 Common Stock 53,054 $1.23 Direct F1, F4
transaction VKTX Stock Option (right to buy) Options Exercise $0 -15,000 -100% $0.000000* 0 28 Mar 2023 Common Stock 15,000 $1.08 Direct F1, F2
transaction VKTX Stock Option (right to buy) Options Exercise $0 -10,000 -100% $0.000000* 0 28 Mar 2023 Common Stock 10,000 $1.04 Direct F1, F2
transaction VKTX Stock Option (right to buy) Options Exercise $0 -24,500 -100% $0.000000* 0 28 Mar 2023 Common Stock 24,500 $4.65 Direct F1, F2
transaction VKTX Stock Option (right to buy) Options Exercise $0 -30,000 -100% $0.000000* 0 28 Mar 2023 Common Stock 30,000 $4.37 Direct F1, F5
transaction VKTX Stock Option (right to buy) Options Exercise $0 -15,000 -100% $0.000000* 0 29 Mar 2023 Common Stock 15,000 $9.13 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person.
F2 25% of the shares subject to the option vested on each one year anniversary of the grant date.
F3 The shares subject to the option vested on the grant date.
F4 23,054 shares vested on the grant date of 01/05/2017 and 25% of the remaining 30,000 shares subject to the option vested on each one year anniversary of the grant date.
F5 One-third of the shares subject to the option vested on each one year anniversary of the grant date.